OVID·690469101·US·equity·Healthcare - Biotechnology-13D/G
OVID (OVID THERAPEUTICS INC) is held by 56 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($23.8M), JANUS HENDERSON GROUP PLC ($23.7M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($13.7M). Net institutional sentiment: Mixed.
See how OVID's score breaks down across 4 SEC sources
Showing 1-20 of 57
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer